Timely Recovery After Subclinical Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

Also called NCT06341101

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06341101
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06341101. Randomized; no masking; primary purpose treatment. Start 2024-03-26 (anticipated); primary completion 2026-03-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Timely Recovery After Subclinical Heart Failure
Acronym
TREASURE
Condition
Heart Failure
Condition
Diastolic Dysfunction
Intervention (Drug)
Perindopril
Lead sponsor
Academisch Ziekenhuis Maastricht (class: other)
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (class: other)

Record details

Record id
cardio:ct-nct06341101
Content hash
1efb9be139556fc3f6d31495ab247bad4fd5dda99d84679e11812fee35d99b44